Biohaven Quarterly Balance Sheet
NYSE: BHVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 12.30 +1.82%
Biohaven financial position
As of Jun 30, 2026, Biohaven reported total assets of $370.7 million, down 32.6% from a year earlier against total liabilities of $358.5 million. Shareholders' equity stood at $12.2 million, or 3.3% of assets. The company held $238.0 million in cash and equivalents against $259.5 million of debt, a net debt position of $21.4 million.
The current ratio (current assets divided by current liabilities) was 4.73, meaning short-term assets cover obligations due within a year. Debt-to-equity was 21.23.
Summary generated from market data by MetaCap's automated system. Methodology
Biohaven balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 238.03M | 273.07M | 229.96M | 184.85M | 165.80M | 98.42M | 99.13M | 84.39M | 239.15M | 182.71M | 248.40M | 111.70M |
| Short-Term Investments | 29.83M | 74.74M | 89.18M | 75.37M | 239.18M | 224.33M | 386.86M | 294.43M | 197.80M | 100.71M | 133.42M | 128.90M |
| Total Current Assets | 296.56M | 385.65M | 368.33M | 323.62M | 474.83M | 382.76M | 538.47M | 440.50M | 511.27M | 348.74M | 442.45M | 310.57M |
| Property, Plant & Equipment | 15.09M | 15.26M | 15.96M | 17.52M | 18.59M | 17.79M | 17.32M | 18.28M | 18.66M | 16.69M | 17.19M | 17.67M |
| Goodwill | 1.39M | 1.39M | 1.39M | 1.39M | 1.39M | 1.39M | 1.39M | 1.39M | 1.39M | 1.39M | 1.39M | 1.39M |
| Intangible Assets | 18.40M | 18.40M | 18.40M | 18.40M | 18.40M | 18.40M | 18.40M | 18.40M | 18.40M | 18.40M | 18.40M | 18.40M |
| Total Assets | 370.74M | 466.41M | 451.45M | 409.12M | 550.41M | 458.95M | 615.11M | 510.52M | 582.64M | 418.53M | 513.21M | 382.74M |
| Accounts Payable | 12.11M | 10.42M | 11.64M | 17.49M | 19.63M | 19.14M | 18.03M | 19.74M | 17.26M | 36.38M | 15.58M | 9.52M |
| Total Current Liabilities | 62.66M | 52.08M | 115.93M | 113.02M | 124.32M | 164.03M | 154.23M | 152.29M | 156.21M | 86.59M | 55.42M | 62.18M |
| Long-Term Debt | 259.48M | 241.91M | 238.90M | 268.27M | 257.07M | — | 0 | — | — | — | — | — |
| Total Liabilities | 358.52M | 336.91M | 399.38M | 426.28M | 415.83M | 199.45M | 191.67M | 194.52M | 198.90M | 117.08M | 85.24M | 92.73M |
| Shareholders' Equity | 12.22M | 129.50M | 52.07M | -17.16M | 134.59M | 259.50M | 423.44M | 316.01M | 383.74M | 301.45M | 427.98M | 290.01M |
| Retained Earnings | -2.35B | -2.22B | -2.08B | -1.94B | -1.77B | -1.57B | -1.35B | -1.16B | -998.57M | -678.80M | -499.29M | -354.54M |
| Total Debt | 259.48M | 241.91M | 238.90M | 268.27M | 257.07M | — | 0 | — | — | — | — | — |
| Net Cash (Debt) | 8.39M | 105.91M | 80.24M | -8.05M | 147.91M | 322.75M | 485.99M | 378.82M | 436.95M | 283.42M | 381.82M | 240.60M |
| Shares Outstanding | 151.02M | 150.51M | 132.78M | 105.80M | 105.78M | 102.10M | 101.22M | 94.90M | 92.35M | 81.81M | 81.12M | 68.36M |
This table shows 12 quarterly periods of Biohaven's balance sheet, from Q2 2026 back to Q3 2023, across 16 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow BHVN's reporting calendar. What is a balance sheet?